National Academies Press: OpenBook
« Previous: Appendix A: Committee Conclusions and Recommendations from Previous Reports
Suggested Citation:"Appendix B: Public Meeting Agenda." Institute of Medicine. 2002. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10393.
×

Appendix B
Public Meeting Agenda March 11, 2002

Immunization Safety Review Committee

Hepatitis B Vaccine and Neurological Disorders

Foundry Building, Room 2004

Washington, DC

8:30–8:45 am

Welcome and Introduction

Marie McCormick, MD, ScD

Committee Chair

8:45–9:00 am

Clinical Description and Diagnosis of Multiple Sclerosis

Emmanuelle Waubant, MD

University of California, San Francisco Multiple Sclerosis Center

(co-author of commissioned paper posted on IOM website)

9:00–9:30 am

Pharmacovigilance and Case-Control Study of Hepatitis B Vaccine and Multiple Sclerosis

Bernard Begaud, MD, PhD (Presented via conference call)

Annie Fourrier, PharmD, MPH (Presented via conference call)

Universite Victor Segalen Bordeaux, France

9:30–10:15 am

Risk of Multiple Sclerosis Relapse After Immunization: European Database for Multiple Sclerosis

Suggested Citation:"Appendix B: Public Meeting Agenda." Institute of Medicine. 2002. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10393.
×

 

Samy Suissa, PhD

McGill University

10:15–10:30 am

Break

10:30–11:15 am

Risk of Multiple Sclerosis After Hepatitis B Immunization: The Nurses’ Health Study

Alberto Ascherio, MD, DrPH

Harvard University

11:15 am–12:00 pm

Risk of Demyelinating Disease After Hepatitis B Vaccination: The Vaccine Safety Datalink

Frank DeStefano, MD, MPH

Centers for Disease Control and Prevention

12:00 pm–1:00 pm

Lunch

1:00–1:45 pm

Possible Mechanisms for Hepatitis B Vaccine-Induced Multiple Sclerosis and Other Demyelinating Diseases

Emmanuelle Waubant, MD

University of California, San Francisco Multiple Sclerosis Center

(co-author of commissioned paper posted on IOM website)

1:45–2:30 pm

Recommendations for Newborn and Infant Hepatitis B Vaccination Historical Perspective

Neal Halsey, MD

Johns Hopkins University

Recent Analyses of Hepatitis B Viral Infections in Children

Eric Mast, MD

National Center for Infectious Diseases

Centers for Disease Control and Prevention

Suggested Citation:"Appendix B: Public Meeting Agenda." Institute of Medicine. 2002. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10393.
×

2:30–3:15 pm

Update on Communications Activities, National Immunization Program, Centers for Disease Control and Prevention

Glen Nowak, PhD

Centers for Disease Control and Prevention

3:15–4:00 pm

Public Comment Session and Discussion

4:00 pm

Adjourn

Suggested Citation:"Appendix B: Public Meeting Agenda." Institute of Medicine. 2002. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10393.
×
Page 100
Suggested Citation:"Appendix B: Public Meeting Agenda." Institute of Medicine. 2002. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10393.
×
Page 101
Suggested Citation:"Appendix B: Public Meeting Agenda." Institute of Medicine. 2002. Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press. doi: 10.17226/10393.
×
Page 102
Next: Appendix C: Chronology of Important Events Regarding Vaccine Safety »
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders Get This Book
×
Buy Paperback | $42.00 Buy Ebook | $33.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Immunization to protect infants and children from vaccine-preventable diseases is one of the greatest achievements of public health. Immunization is not without risks, however. It is well established, for example, that the oral polio vaccine can on rare occasion cause paralytic polio.

The Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the available evidence on a series of immunization safety concerns. The committee is charged with examining three immunization safety hypotheses each year during the three-year study period (2001- 2003). While all of the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. In this report, which is the fourth in the series, the committee examines the hypothesis that the hepatitis B vaccine increases the risk for demyelinating disorders of the central or peripheral nervous systems, including multiple sclerosis (MS) and Guillain-Barré syndrome (GBS).

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!